Chulabhorn Royal Academy (CRA) has officially announced the completion of the TIGERS-X payload, a cutting-edge space biopharmaceutical experiment designed to study drug formulation in microgravity using Lab-on-Chip technology. The payload represents a significant milestone in Thailand’s growing role in space-enabled biomedical research, integrating precision microfluidics with spaceflight-ready hardware.
The TIGERS-X experiment focuses on how microgravity affects the mixing, crystallization, and stability of pharmaceutical compounds at the microscale. By leveraging Lab-on-Chip systems, researchers are able to conduct highly controlled experiments with minimal sample volumes, enabling new insights into drug behavior that are difficult to replicate under Earth’s gravity. The results are expected to contribute to the development of more stable and effective medications, both for space missions and terrestrial healthcare applications.
Beyond its scientific objectives, TIGERS-X is positioned as a technology demonstrator for future space-based pharmaceutical manufacturing. CRA emphasized that the successful completion of the payload highlights Thailand’s capability to design and build advanced experimental systems for operation aboard the International Space Station (ISS), paving the way for more ambitious collaborations in low Earth orbit.